
Please try another search
Investing.com -- Biotest AG (ETR:BIOG_p) reported a 6% rise in sales for 2024, reaching €726.2 million, driven by strong demand for its immunoglobulin products, particularly Yimmugo, which received...
BioGaia reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and strategic product launches. Sales for the quarter rose by 23% to SEK 365 million, while...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review